SKI Market

A+| A| A-|

Indian Indices

Sensex

78,285.07 521.16
( 0.67%)

Global Indices

Nasdaq

52,921.07 594.83
(1.14%)

Dow Jones

7,504.24 0.01
(0.00%)

Hang Seng

69,576.15 -167.92
(-0.24%)

Nikkei 225

10,649.07 -29.96
(-0.28%)

Forex

USD-INR

95.28 0.28
(0.30%)

EUR-INR

108.75 0.54
(0.50%)

GBP-INR

126.99 1.06
(0.84%)

JPY-INR

0.59 0.01
(0.97%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9559391

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

37.46

114730.36

EPS(TTM)

Face Value()

Div & Yield %

36.69

0.58

Back

Garnet Construction reports standalone net profit of Rs 10.01 crore in the December 2025 quarter

Feb 14,2026

Net profit of Garnet Construction reported to Rs 10.01 crore in the quarter ended December 2025 as against net loss of Rs 0.46 crore during the previous quarter ended December 2024. Sales rose 1710.34% to Rs 15.75 crore in the quarter ended December 2025 as against Rs 0.87 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	15.75	0.87	1710
OPM %	87.49	-26.44	-
PBDT	13.43	-0.39	LP
PBT	13.26	-0.48	LP
NP	10.01	-0.46	LP

78,285.07 521.16 ( 0.67%)

52,921.07 594.83 (1.14%)

7,504.24 0.01 (0.00%)

69,576.15 -167.92 (-0.24%)

10,649.07 -29.96 (-0.28%)

95.28 0.28 (0.30%)

108.75 0.54 (0.50%)

126.99 1.06 (0.84%)

0.59 0.01 (0.97%)